The Proof with Simon Hill cover image

New heart disease test you should order | Thomas Dayspring, Md

The Proof with Simon Hill

CHAPTER

Mechanism and Impact of PCSK9 Inhibitors on LP little A Levels

This chapter explains how PCSK9 inhibitors influence LP little A levels by interacting with LDL receptors and APO-B particles, discussing the benefits of combining high-dose statins with PCSK9 inhibitors. It explores various drugs' effects on reducing ApoB and LP little a concentrations to mitigate heart disease risks, including the mechanisms of PCSK9 inhibitors, CETP inhibitors, and movalalapin.

00:00
Transcript
Play full episode

Remember Everything You Learn from Podcasts

Save insights instantly, chat with episodes, and build lasting knowledge - all powered by AI.
App store bannerPlay store banner